Appendix Adenocarcinoma — Trials

Appendix Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 13%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07795749	Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)	recruiting	Phase 2	55	University of California, IrvineOTHER	1	Aug 31, 2026	clinicaltrials
NCT07658196	TLR9 Immunotherapy for Peritoneal Carcinomatosis(TIPC)	recruiting	Phase 1	24	Brown UniversityOTHER	1	Aug 27, 2026	clinicaltrials